Shares in FTSE 100 giant AstraZeneca (LSE:AZN) are up 22% in three months, but is it a good time to buy? The post Up 22% in 3 months! Should investors consider buying shares in this FTSE 100 pharma ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

There’s a lot of froth in the stock market right now. Yet at the same time, there are also a lot of bargains for long-term investors. The post While there are bubbles in the stock market, this sector ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

GSK plc announced plans to invest $30 billion in U.S. research and manufacturing over the next five years and entered a $500 ...

NICE recommends ViiV Healthcare's Apretude as the first injectable PrEP for HIV prevention, offering an alternative to daily ...

GSK plc has announced the purchase of 310,000 of its own ordinary shares as part of its ongoing buyback program. This transaction, executed through BNP Paribas SA, is part of a broader strategy to ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best stocks to buy according to Jim Simons’ Renaissance Technologies. On ...

CEO Emma Walmsley said GSK has had a minimal role in an effort by the FDA to update the prescribing information of the ...

If you are on the fence about what to do with your GSK shares, you are not alone. The stock has seen some interesting moves ...

Lloyds Banking Group today made a big increase to the amount it will need to cover motor finance mis-selling compensation.